ERBB2 c.2974G>A ;(p.E992K)

Variant ID: 17-37883071-G-A

NM_004448.2(ERBB2):c.2974G>A;(p.E992K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.

Cancer Discovery
Jänne, Pasi A PA; Baik, Christina C; Su, Wu-Chou WC; Johnson, Melissa L ML; Hayashi, Hidetoshi H; Nishio, Makoto M; Kim, Dong-Wan DW; Koczywas, Marianna M; Gold, Kathryn A KA; Steuer, Conor E CE; Murakami, Haruyasu H; Yang, James Chih-Hsin JC; Kim, Sang-We SW; Vigliotti, Michele M; Shi, Rong R; Qi, Zhenhao Z; Qiu, Yang Y; Zhao, Lihui L; Sternberg, David D; Yu, Channing C; Yu, Helena A HA
Publication Date: 2022-01

Variant appearance in text: ERBB2: E992K
PubMed Link: 34548309
Variant Present in the following documents:
  • 74.pdf
View BVdb publication page



Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs.

Frontiers In Oncology
Ma, Li L; Li, Haoyang H; Wang, Dongpo D; Hu, Ying Y; Yu, Mengjun M; Zhang, Quan Q; Qin, Na N; Zhang, Xinyong X; Li, Xi X; Zhang, Hui H; Wu, Yuhua Y; Lv, Jialin J; Yang, Xinjie X; Yu, Ruoying R; Zhang, Shucai S; Wang, Jinghui J
Publication Date: 2021

Variant appearance in text: ERBB2: E992K
PubMed Link: 33842353
Variant Present in the following documents:
  • Main text
  • fonc-11-643199.pdf
View BVdb publication page